Cargando…
Safety and efficacy evaluation of Ayurvedic treatment (Arjuna powder and Arogyavardhini Vati) in dyslipidemia patients: A pilot prospective cohort clinical study
Cardiovascular disease has multifaceted in which dyslipidemia, inflammation, and immunity play an important role. Arjuna powder and Arogyavardhini Vati used for centuries has potential for combating these factors. Therefore, the objective of this study was to evaluate the safety and efficacy of Ayur...
Autores principales: | Kumar, Gajendra, Srivastava, Amita, Sharma, Surinder Kumar, Gupta, Yogendra Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611635/ https://www.ncbi.nlm.nih.gov/pubmed/23559790 http://dx.doi.org/10.4103/0974-8520.105238 |
Ejemplares similares
-
The hypolipidemic activity of Ayurvedic medicine, Arogyavardhini vati in Triton WR-1339-induced hyperlipidemic rats: A comparison with fenofibrate
por: Kumar, Gajendra, et al.
Publicado: (2013) -
Efficacy & safety evaluation of Ayurvedic treatment (Ashwagandha powder & Sidh Makardhwaj) in rheumatoid arthritis patients: a pilot prospective study
por: Kumar, Gajendra, et al.
Publicado: (2015) -
Safety evaluation of mercury based Ayurvedic formulation (Sidh Makardhwaj) on brain cerebrum, liver & kidney in rats
por: Kumar, Gajendra, et al.
Publicado: (2014) -
Overdose effect of aconite containing Ayurvedic Medicine (‘Mahashankha Vati’)
por: Panda, Ashok Kumar, et al.
Publicado: (2010) -
Validation of therapeutic anti-inflammatory potential of Arjuna Ksheera Paka – A traditional Ayurvedic formulation of Terminalia arjuna
por: Dube, Nivedita, et al.
Publicado: (2016)